Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Soluble beta-1,3/1,6-glucan for oral mucositis in head and neck cancer
NCT00289003Phase 2Completed
- Sponsor
- Biotec Pharmacon ASA
- Start
- Oct 2003
- Modality
- Biologic, Polysaccharide
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in oral mucositis (OM) comparing SBG with Placebo (2 arms). Primary endpoint: grade of mucositis. Started Oct 2003; status: completed.
02
Drugs
Imprime PGG
03
Conditions
oral mucositis (OM)
Beyond the preview
Go deeper on NCT00289003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289003.